Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
Clinical trial NCT00407888 · COMPLETED
Trial details
- NCT number
- NCT00407888
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.